MYB Antikörper (AA 119-135)
Kurzübersicht für MYB Antikörper (AA 119-135) (ABIN6940143)
Target
Alle MYB Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 119-135
-
Aufreinigung
- Purified by Protein A/G
-
Immunogen
- A synthetic peptide, corresponding to aa 119-135 (RRKVEQEGYPQESSKAG) of c-myb onco protein, coupled to KLH
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
-
Positive Control: Jurkat, MOLT-4, COLO or BT-20 cells. Colon or breast carcinomas.
Known Application: ELISA (Use Ab at 2-4 μg/mL for coating) (Order Ab without BSA), Optimal dilution for a specific application should be determined.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 200 μg/mL
-
Buffer
- 10 mM PBS with 0.05 % BSA & 0.05 % azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-80 °C
-
Informationen zur Lagerung
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
Haltbarkeit
- 24 months
-
-
- MYB (V-Myb Myeloblastosis Viral Oncogene Homolog (Avian) (MYB))
-
Andere Bezeichnung
- MYB
-
Hintergrund
- The highly leukemogenic avian retrovirus E26 contains two oncogenes, v-Myb and v-Ets, which are expressed together as a fusion protein. The cellular homolog of v-Myb, designated c-Myb, encodes a transcription factor. Deletion or disruption of a negative regulatory domain mapping within the carboxy-terminal domain of c-Myb results in enhanced transactivating capacity and in parallel, leads to activation of its ability to transform hemopoietic cells. c-Myb is expressed preferentially, but not exclusively, in immature hemopoietic cells and its expression decreases as cells differentiate.
-
Molekulargewicht
- ~75kDa
-
Gen-ID
- 4602
-
UniProt
- P01104
-
Pathways
- Chromatin Binding, Positive Regulation of Immune Effector Process
Target
-